Patents by Inventor Clare Slaney

Clare Slaney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC POLYPEPTIDES FOR ENGAGEMENT OF CAR EXPRESSING IMMUNE CELLS WITH ANTIGEN PRESENTING CELLS AND USES THEREOF
    Publication number: 20240150482
    Abstract: The present application is directed to bispecific polypeptides comprising a first domain binding an antigen on an antigen presenting cell (ARC) and a second domain binding an antigen on an immune cell expressing a chimeric antigen receptor (CAR). Nucleic acids, vectors and host cells used in producing the polypeptide of the invention are also disclosed. Compositions comprising the bispecific polypeptides and methods of treating cancer and stimulating activation and expansion of immune cells in vivo and in vitro are also disclosed.
    Type: Application
    Filed: November 13, 2023
    Publication date: May 9, 2024
    Applicant: Peter MacCallum Cancer Institute
    Inventors: Michael Kershaw, Clare Slaney, Bianca Von Scheidt
  • NOVEL CAR
    Publication number: 20240101638
    Abstract: The invention relates to a chimeric antigen receptor (CAR) that binds to mesothelin and cells that express the CAR, as well as uses thereof for the treatment of cancer.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 28, 2024
    Applicant: Currus Biologics Pty Ltd
    Inventors: Samantha Cobb, Michael Kershaw, Clare Slaney
  • Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof
    Patent number: 11866504
    Abstract: The present application is directed to bispecific polypeptides comprising a first domain binding an antigen on an antigen presenting cell (ARC) and a second domain binding an antigen on an immune cell expressing a chimeric antigen receptor (CAR). Nucleic acids, vectors and host cells used in producing the polypeptide of the invention are also disclosed. Compositions comprising the bispecific polypeptides and methods of treating cancer and stimulating activation and expansion of immune cells in vivo and in vitro are also disclosed.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: January 9, 2024
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Michael Kershaw, Clare Slaney, Bianca Von Scheidt
  • BISPECIFIC POLYPEPTIDES FOR ENGAGEMENT OF CAR EXPRESSING IMMUNE CELLS WITH ANTIGEN PRESENTING CELLS AND USES THEREOF
    Publication number: 20220017628
    Abstract: The present application is directed to bispecific polypeptides comprising a first domain binding an antigen on an antigen presenting cell (ARC) and a second domain binding an antigen on an immune cell expressing a chimeric antigen receptor (CAR). Nucleic acids, vectors and host cells used in producing the polypeptide of the invention are also disclosed. Compositions comprising the bispecific polypeptides and methods of treating cancer and stimulating activation and expansion of immune cells in vivo and in vitro are also disclosed.
    Type: Application
    Filed: October 29, 2019
    Publication date: January 20, 2022
    Applicant: Peter MacCallum Cancer Institute
    Inventors: Michael Kershaw, Clare Slaney, Bianca Von Scheidt